92 related articles for article (PubMed ID: 6318064)
21. Regulation of specific forms of cyclic nucleotide phosphodiesterases in cultured cells.
Manganiello VC; Yamamoto T; Elks M; Lin MC; Vaughan M
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():291-301. PubMed ID: 6326529
[No Abstract] [Full Text] [Related]
22. Genetic analysis of cyclic nucleotide phosphodiesterases in Drosophila melanogaster.
Kiger JA; Davis RL; Salz H; Fletcher T; Bowling M
Adv Cyclic Nucleotide Res; 1981; 14():273-88. PubMed ID: 6269382
[No Abstract] [Full Text] [Related]
23. [Cardiotropic effects of luliberin. Interaction with rat heart sarcolemmal membrane].
Isachenkov VA; Bakalkin GIa; Kravtsov GM; Komissarova EN; Pokudin NI
Biokhimiia; 1979 Mar; 44(3):387-93. PubMed ID: 223668
[TBL] [Abstract][Full Text] [Related]
24. Genetic analysis of cyclic nucleotide phosphodiesterases in S49 mouse lymphoma cells.
Bourne HR; Brothers VM; Kaslow HR; Groppi V; Walker N; Steinberg F
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():185-94. PubMed ID: 6326523
[No Abstract] [Full Text] [Related]
25. Metabolic heterogeneity of the nephron.
Kurokawa K
Nihon Jinzo Gakkai Shi; 1981 Jul; 23(7):973-80. PubMed ID: 6275154
[No Abstract] [Full Text] [Related]
26. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3?
Kass DA
Circulation; 2007 Jul; 116(3):233-5. PubMed ID: 17638937
[No Abstract] [Full Text] [Related]
27. An inhibitor of the toad bladder cyclic AMP system and theophylline-stimulated Na+ transport.
Besley GT; Frith DA; Snart RS
Steroids Lipids Res; 1974; 5(5-6):365-79. PubMed ID: 4376626
[No Abstract] [Full Text] [Related]
28. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
Kireeva NN; Bobruskin ID; Severin SE
Biokhimiia; 1995 May; 60(5):694-708. PubMed ID: 7662796
[TBL] [Abstract][Full Text] [Related]
29. Implications of PDE4 structure on inhibitor selectivity across PDE families.
Ke H
Int J Impot Res; 2004 Jun; 16 Suppl 1():S24-7. PubMed ID: 15224132
[TBL] [Abstract][Full Text] [Related]
30. [Role of adenylate cyclase and the mechanism controlling platelet aggregation].
Yoshida N; Aoki N
Rinsho Byori; 1979; Suppl 40():47-53. PubMed ID: 233107
[No Abstract] [Full Text] [Related]
31. [The possible role of disruptions of the cyclic AMP system in the pathogenesis of thyrotoxic myopathies].
Kazakov VM; Malakhovskiĭ VK; Khokhlov AP; Mikhaĭlov KP; Lozovskiĭ VT
Vopr Med Khim; 1983; 29(6):69-73. PubMed ID: 6322441
[TBL] [Abstract][Full Text] [Related]
32. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
Rose RJ; Liu H; Palmer D; Maurice DH
Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930
[TBL] [Abstract][Full Text] [Related]
33. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
[TBL] [Abstract][Full Text] [Related]
34. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
35. [Activity of Ca++-ATPase and enzymes of cycl AMP metabolism in the nervous tissue of rats at early stages of acute radiation sickness].
Vasil'ev AN; Gavrileĭ VI; Grinchuk DV; Maĭdaniuk AV; Matyshevskaia OP
Radiobiologiia; 1982; 22(6):815-7. PubMed ID: 6296914
[No Abstract] [Full Text] [Related]
36. Distinct profiles of phosphodiesterase isozymes in cultured cells derived from nonpigmented and pigmented ocular ciliary epithelium.
Bode DC; Hamel LT; Wax MB
J Pharmacol Exp Ther; 1993 Dec; 267(3):1286-91. PubMed ID: 8263791
[TBL] [Abstract][Full Text] [Related]
37. Beta-adrenergic receptor regulation of a cyclic AMP phosphodiesterase in C6 glioma cells.
Schwartz JP; Onali P
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():195-203. PubMed ID: 6326524
[No Abstract] [Full Text] [Related]
38. [Bioluminescence and its analytic applications].
Ricci C
Quad Sclavo Diagn; 1983 Dec; 19(4):415-31. PubMed ID: 6146159
[No Abstract] [Full Text] [Related]
39. [Metabolic properties of Hürthle cell adenoma].
Califano G; Abate S; Ferulano GP; Caputo G; Catapano R; Macchia V
Minerva Med; 1980 Jun; 71(23):1657-60. PubMed ID: 6247676
[No Abstract] [Full Text] [Related]
40. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes.
Picq M; Dubois M; Grynberg A; Lagarde M; Prigent AF
J Mol Cell Cardiol; 1996 Oct; 28(10):2151-61. PubMed ID: 8930810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]